Deleterious alterations in the cytokine secretome, in combination with our sequencing data suggesting KEAP1 mutant cells have an increased capability to regulate immune cell trafficking, led us to hypothesize that these KEAP1-deficient cancers are re-configuring their immune microenvironments to be more advantageous to the cancer. Here, KEAP1 is linked to cancer.